Trade Summary

5 days ago, Soteropoulos Paula, serving as Dir at Dianthus Therapeutics, Inc. /De/ (DNTH), sold 599 shares at $80.11 per share, for a total transaction value of $47,986.00.

This sale represents a 100.00% decrease in Soteropoulos Paula's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 31, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 1, 2026, 1 day after the trade was made.

Dianthus Therapeutics, Inc. /De/ operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.